Genome-wide DNA methylation profiling also revealed prominent hypomethylation of interferon-stimulated genes such as MX1, IFI44L, and PARP9 in B cells from pSS patients, suggesting that methylation levels at different IFN-stimulated gene loci may be biomarkers for different autoimmune diseases [194]. This evidence concerns the gene IFNA1 and autoimmune disease.